Article

The Immunoreactivity Patterns of BRAF VE1 and its Diagnostic Value in Brain Tumors

2022-05-04

Abstract excerpt

<h4>Background: </h4> BRAF-V600E mutation is considered as a material biomarker with diagnosis, prognosis and prediction in brain tumors. At present, molecular detection remains the most responsible approach for BRAF V600E mutation. The accuracy of Immunohistochemical test for Anti-BRAF VE1 antibody has rarely been systematically evaluated in brain tumors, despite it is widely used in pathological diagnostic pract...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: f3a79b63-7883-5a5c-b8bf-79ee1813188b
DOI: 10.21203/rs.3.rs-46822/v2

Open publication

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Click a neighbor to travelStep 1 · 12 closest

The Immunoreactivity Patterns of BRAF VE1 and its Diagnostic Value in Brain TumorsDOI 10.21203/rs.3.rs-46822/v2Read

Immunohistochemical detection of the BRAF V600E mutation in melanoma patients with monoclonal antibody VE1.Semantic proximity Read

[Utility and evaluation of immunohistochemical detection of BRAF V600E mutation in melanoma].Semantic proximity Read

Cells with ganglionic differentiation frequently stain for VE1 antibody: a potential pitfall.Semantic proximity Read

Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody.Semantic proximity Read

BRAF VE1 immunoreactivity patterns in epithelioid glioblastomas positive for BRAF V600E mutation.Semantic proximity Read

Immunohistochemistry as a reliable method for detection of BRAF-V600E mutation in melanoma: a systematic review and meta-analysis of current published literature.Semantic proximity Read

BRAF V600E mutation-specific antibody: A review.Semantic proximity Read

Detection of BRAF V600E Mutation in Ganglioglioma and Pilocytic Astrocytoma by Immunohistochemistry and Real-Time PCR-Based Idylla Test.Semantic proximity Read

VE1 immunohistochemical detection of the BRAF V600E mutation in thyroid carcinoma: a review of its usefulness and limitations.Semantic proximity Read

VE1 immunohistochemistry predicts BRAF V600E mutation status and clinical outcome in colorectal cancer.Semantic proximity Read

Effective Treatment of a BRAF V600E-Mutant Epithelioid Glioblastoma Patient By Vemurafenib: A Case ReportSemantic proximity Read

Immunohistochemistry with Anti-BRAF V600E (VE1) Mouse Monoclonal Antibody is a Sensitive Method for Detection of the BRAF V600E Mutation in Colon Cancer: Evaluation of 120 Cases with and without KRAS Mutation and Literature Review.Semantic proximity Read